U.S. Logistics Stock News

Public Service Enterprise Group is preparing its grid and customers for an upcoming extreme heatwave expected to bring sustained high temperatures. The company is focusing on infrastructure readiness, safety guidance and outreach to vulnerable customers ahead of the heat event. These efforts highlight Public Service Enterprise Group's approach to resiliency and community support during climate related stress on the power system. Public Service Enterprise Group, traded as NYSE:PEG, is...

Political risk is no longer just background noise for investors, it is starting to shape which stocks could face pressure and which might see fresh demand as trust in US legal and regulatory institutions comes under strain. With senior legal figures warning about retribution prosecutions and signs of stress inside the Department of Justice, companies closely tied to enforcement, oversight, and risk management are squarely in focus. This article breaks down three stocks exposed to the latest...

Why this patent and board news matters for Xeris Biopharma Holdings stock Xeris Biopharma Holdings (XERS) has drawn fresh attention after securing a USPTO notice of allowance for a Keveyis related patent that may extend protection to 2039, alongside several board and leadership changes. For investors, the patent development is important because it relates directly to a marketed therapy, Keveyis, and the company has indicated it plans to seek inclusion of this intellectual property in the...

Quest Diagnostics stock has delivered a 76.9% total return over the past five years, and the latest valuation work using a Discounted Cash Flow (DCF) estimate points to the shares still trading at roughly a 33.3% discount to intrinsic value, even as earnings-based multiples look closer to fair. With the company in the headlines for new diagnostics offerings and upcoming results, investors are weighing whether that apparent discount reflects opportunity or embedded risks. A 76.9% five-year...

FactSet Research Systems (FDS) opened its Q3 2026 scorecard with revenue of US$622.9 million and basic EPS of US$3.51, set against trailing twelve month revenue of about US$2.4 billion and EPS of US$15.27 that frame the current run rate. Over recent quarters the company has seen revenue progress from US$570.7 million in Q2 2025 to US$596.9 million in Q4 2025 and US$622.9 million in Q3 2026. Quarterly EPS has moved from US$3.81 to US$4.07 and then US$3.51, which feeds directly into a trailing...

With inflation trends, interest rate expectations and growth signals all pulling in different directions, many investors are looking for stocks where management has meaningful skin in the game and sees room for further expansion. The Fast Growing Stocks With High Insider Ownership screener focuses on companies with stronger growth potential, supported by positive views from both analysts and insiders who are closely tied to future outcomes. This article highlights 3 stocks from that screener...

Earlier in 2026, Barclays initiated coverage on Zurn Elkay Water Solutions with an overweight rating and a US$59.00 price objective, while the company also declared a US$0.11 per share quarterly cash dividend payable in June 2026. Together, the upbeat Barclays initiation and steady dividend signal growing institutional interest in Zurn Elkay’s role in non-residential construction and water management trends. Next, we’ll examine how Barclays’ positive initiation, highlighting non-residential...

On 1 July 2026, Datavault AI Inc. announced a proposed partnership with Patriot Strategic Metals LLC to build a Strategic Materials Acquisition Platform, including a Phase I program of up to US$700.00 million with about US$62.00 million earmarked for Datavault AI’s technology integration and RWA tokenization infrastructure. A distinctive feature of the proposal is Datavault AI’s intended 25% participation in net distributable platform profits, which could align its AI-enabled digital...

Index additions put Olema Pharmaceuticals in front of more institutional investors Olema Pharmaceuticals (OLMA) has just been added to several Russell growth benchmarks, a change that puts the stock in front of more index-tracking and institutional investors that follow these indices. See our latest analysis for Olema Pharmaceuticals. At a share price of $12.64, Olema Pharmaceuticals has seen short term momentum build, with a 1 month share price return of 18.24% and a 7 day move of 10.59%,...

Geopolitical tensions in Eastern Europe are reshaping how investors think about risk and opportunity, particularly as countries like Lithuania and Finland reopen the door to potential nuclear deployments. These moves, alongside a possible build up of U.S. nuclear capable forces on NATO’s eastern flank, are feeding fresh volatility across defense, energy, and broader European equities. For investors, the question is not just who might benefit, but who could be hurt if security concerns keep...

In recent weeks, Palomar Holdings raised its adjusted net income guidance to US$262 million–US$278 million and highlighted stronger premium retention, expanded product lines, and progress in its crop insurance ambitions, signaling a shift in its business mix. This combination of higher earnings expectations and a sharpened focus on specialty areas like crop insurance could meaningfully influence how investors assess Palomar’s growth and risk profile. We’ll now explore how Palomar’s higher...

Multiple law firms have filed class action lawsuits alleging Calix (NYSE:CALX) made materially false or misleading statements about gross margins and supply chain conditions. The complaints focus on advanced stockpiling of low cost memory components that allegedly boosted Q1 gross margins before the company later disclosed margin pressure. After disclosures about the exhaustion of these lower cost supplies and rising component costs, investors allegedly experienced losses tied to share price...

With central banks focused on inflation control and signalling possible rate hikes, value stocks with solid balance sheets and consistent dividends can look relatively interesting for investors who want income and are wary of paying high multiples. This article looks at three stocks from a Value Stocks screener that appear closely tied to the current monetary policy backdrop, where higher borrowing costs and ongoing geopolitical and supply chain pressures are shaping expectations. Each stock...

Bassett Furniture Industries (BSET) opened Q2 2026 with revenue of US$83.8 million and basic EPS of US$0.24, alongside trailing twelve month revenue of US$332.9 million and EPS of US$0.64 that reflect the strong year over year earnings rebound and margin uplift highlighted in the recent data. Over recent quarters, the company has seen revenue move between US$80.1 million and US$88.7 million with quarterly EPS ranging from US$0.09 to US$0.24, while trailing twelve month EPS has shifted from a...

When the labor force shrinks, as it has with participation falling to 61.5% and prime age workers stepping back, staffing and recruitment stocks can sit right on the fault line of change. Fewer active jobseekers, softer hiring in leisure and hospitality, and a 59% employment to population ratio can all reshape demand for flexible workforce solutions. This article looks at how that backdrop relates to our Staffing & Recruitment Companies screener and highlights 3 stocks that appear positively...

Greenbrier Companies (GBX) opened Q3 2026 with total revenue of US$576.5 million and basic EPS of US$0.61, alongside trailing twelve month EPS of US$3.46 on revenue of US$2.63 billion. Over the past few quarters, the company has seen revenue move between US$762.1 million and US$576.5 million, while quarterly EPS ranged from US$1.93 to US$0.49, giving investors a clear view of how earnings track alongside shifts in the top line. With net profit margin running lower than a year ago and a recent...

iQIYI (NasdaqGS:IQ) has appointed Mr. Ying Tian as its new Chief Financial Officer. Mr. Tian brings experience from Baidu AI Cloud and Huawei, with a background that combines finance and technology. The appointment highlights iQIYI's focus on financial discipline and AI related transformation. iQIYI is making this leadership change at a time when its share price is around $1.015, with the stock down 50.0% year to date and down 43.0% over the past year. Over a longer stretch, the stock is...

Dutch Bros (NYSE:BROS) has rolled out limited-time Firecracker Rebel and Firecracker Lemonade drinks tied to the Fourth of July holiday. The company is growing its retail footprint with a new drive-thru location in Melbourne, Florida. Dutch Bros has also announced a future site in Hammond, Indiana, extending its presence into another key market. For investors tracking Dutch Bros, these product and store updates add another layer to a story that is often framed mainly around valuation and...

PayPay (PAYP) has just wrapped up FY 2026 with fourth quarter revenue of ¥101,395 million and basic EPS of ¥20.98, while trailing twelve month EPS reached ¥180.42 on revenue of ¥378,407 million, setting a clear earnings season marker for investors. Over the past two reported years, the company has seen revenue move from ¥252,855 million to ¥378,407 million and basic EPS shift from a loss of ¥6.09 to ¥180.42, supported by trailing net profit margin of 30.4% versus 12.1% a year earlier, which...

Coherent stock has delivered a very large 3 year return while the latest valuation checks pull in different directions, with the Discounted Cash Flow (DCF) intrinsic value suggesting the shares trade at a premium and market multiples screening as more forgiving. Over the past 3 years, Coherent has returned roughly 5.8x an investor's original stake, which sets a high bar for what the current share price is already pricing in. The Nvidia backed optical networking partnership can support long...

Artificial intelligence in healthcare sits at the crossroads of two forces investors are watching closely today: inflation sensitive policy shifts and fast moving technology that aims to cut costs and improve outcomes. While central banks weigh interest rate decisions and hospitals face pressure to do more with less, AI driven tools are being applied to diagnostics, treatment decisions, and day to day clinical workflows. The Transformative AI Healthcare Stocks screener focuses on companies...

Pediatrix Medical Group, Inc. (NYSE: MD) was added in June 2026 to both the Russell 2000 Value-Defensive Index and the Russell 2000 Defensive Index, placing the company within key benchmarks tracked by many institutional investors. This dual inclusion highlights how the market increasingly views Pediatrix as a defensive healthcare name with characteristics that align with value-oriented, risk-aware investment mandates. We’ll now consider how Pediatrix’s addition to the Russell 2000 Defensive...

Churchill Downs (CHDN) is back in focus after reporting Q1 2026 results that featured revenue growth, adjusted EBITDA margin expansion, and EPS outperformance, supported by cash generation, HRM expansion, and debt reduction. See our latest analysis for Churchill Downs. Churchill Downs shares have picked up momentum in the short term, with a 1-day share price return of 1.97% and a 7-day share price return of 8.25%. This comes even though the year to date share price return is down 18.79% and...

Disc Medicine (IRON) amended its loan agreement with Hercules Capital, drawing US$30 million immediately and extending access to multiple future tranches. This financing move could influence how investors view its cash runway and clinical plans. See our latest analysis for Disc Medicine. Disc Medicine's latest debt amendment comes after a period where short term share price momentum has been positive, with a 90 day share price return of 14.99%. However, the year to date share price return has...